KeyBanc upgraded National Health Investors (NHI) to Overweight from Sector Weight with an $80 price target The firm says the company has “multiple value-creation opportunities” to drive upside to estimates. It sees incremental unscheduled deferral repayments beyond what is assumed in guidance and better execution on investments relative to expectations. National Health has the potential to enhance its internal growth profile and drive upside to 2025 guidance and consensus estimates, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- Apple upgraded, Adobe downgraded: Wall Street’s top analyst calls
- National Health Investors upgraded to Buy from Hold at Truist
- National Health Investors price target raised to $77 from $76 at Truist
- National Health Investors Updates Investment Pipeline Strategy
- National Health Investors Holds 2025 Annual Meeting